Treatment of Moloney virus-induced leukemia with cyclophosphamide and specifically sensitized allogeneic cells.
D000818:Animals; D000951:Antigens, Neoplasm; D064987:Cell- and Tissue-Based Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006648:Histocompatibility; D007942:Leukemia, Experimental / Q000628:therapy*; D008297:Male; D051379:Mice; D008979:Moloney murine leukemia virus / Q000472:pathogenicity*; D012513:Sarcoma, Experimental / Q000401:mortality; D013154:Spleen / Q000166:cytology / Q000276:immunology*
D000951:Antigens, Neoplasm; D003520:Cyclophosphamide